Toradol

Short-Term Pain Management

Toradol is prescribed to manage moderately severe acute pain. It is most frequently used in a hospital setting or immediately following a medical procedure or surgery to help patients manage significant discomfort during the initial recovery phase.

Usage Limitations

This medication is intended for short-term use only. Key aspects of its use include:

• Duration: It should not be used for longer than five days.
• Severity: It is meant for pain that is severe enough to require strong relief, similar to what might be provided by opioid medications.
• Transition: Treatment often begins with an injection (either into a vein or a muscle) and may be followed by oral tablets if continued treatment is necessary within the five-day limit.

What It Is Not Used For

Toradol is not appropriate for all types of pain. It is generally not used for:

• Minor or mild pain.
• Long-term (chronic) pain conditions, such as arthritis.
• Pain that can be managed with less potent medications.

Mechanism of Action

Toradol belongs to a class of medications known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking the action of enzymes in the body called cyclooxygenase (COX-1 and COX-2).

These enzymes are responsible for producing prostaglandins, which are hormone-like chemicals that the body releases at sites of tissue damage or infection. Prostaglandins cause the redness, swelling, and heat associated with inflammation, and they also sensitize nerve endings, which leads to the sensation of pain.

By inhibiting these enzymes and reducing the production of prostaglandins, Toradol helps to alleviate moderate to severe pain and reduce inflammation. It is primarily used for short-term pain management, such as the period immediately following a surgical procedure.

Common Side Effects

While taking Toradol, some people may experience mild symptoms. Common side effects include:

• Headache or dizziness
• Drowsiness
• Nausea, vomiting, or stomach pain
• Indigestion, gas, or constipation
• Diarrhea
• Sweating
• Sores in the mouth

Serious Side Effects

Seek medical attention immediately if you experience any of the following serious symptoms:

• Allergic reactions: Hives, skin rash, swelling of the face or throat, and difficulty breathing.
• Gastrointestinal distress: Bloody or black, tarry stools; vomiting blood or material that looks like coffee grounds.
• Heart and stroke symptoms: Chest pain, shortness of breath, slurred speech, or sudden weakness on one side of the body.
• Kidney issues: Swelling of the arms, legs, or feet; rapid weight gain; or a decrease in urination.
• Liver problems: Yellowing of the eyes or skin, dark urine, or pain in the upper right stomach area.
• Skin conditions: Fever, blisters, or peeling skin.
• Vision changes: Blurred vision or other changes in sight.

Boxed Warning and Duration of Use

Toradol is indicated only for the short-term management of moderately severe acute pain. Treatment must not exceed a total of five days, including both injectable and oral forms. Using the medication longer than five days increases the risk of serious adverse effects.

Gastrointestinal Risks

This medication can cause serious gastrointestinal (GI) adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines. These conditions can occur at any time during use, without warning symptoms, and may be fatal. The risk is significantly higher in elderly patients and those with a history of peptic ulcer disease or GI bleeding.

Cardiovascular Risks

Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of serious cardiovascular thrombotic events, such as heart attack and stroke. This risk may occur early in treatment and may increase with duration of use. Toradol is contraindicated for the treatment of pain before or after coronary artery bypass graft (CABG) surgery.

Kidney and Fluid Balance

Toradol can cause acute kidney failure, especially in patients who are dehydrated or have pre-existing renal impairment. It is contraindicated in patients with advanced renal impairment or those at risk for renal failure due to volume depletion.

Bleeding and Hemostasis

Because it inhibits platelet function, Toradol is contraindicated in patients with suspected or confirmed cerebrovascular bleeding, those with a high risk of bleeding, or those with incomplete hemostasis after surgery.

Pregnancy and Labor

Toradol is contraindicated during labor and delivery because it may adversely affect fetal circulation and inhibit uterine contractions. Starting at 20 weeks of pregnancy, NSAIDs may cause rare but serious kidney problems in an unborn baby, leading to low amniotic fluid and potential complications.

Other Contraindications

• Active peptic ulcer disease or recent gastrointestinal bleeding.
• Known hypersensitivity to ketorolac or other NSAIDs, including patients who have experienced asthma or hives after taking aspirin.
• Concurrent use with other NSAIDs, pentoxifylline, or probenecid.

Pregnancy

The use of Toradol (ketorolac) during pregnancy requires careful consideration with a healthcare provider. Taking this medication starting at 20 weeks of pregnancy or later may cause rare but serious kidney problems in the unborn baby, which can lead to low levels of amniotic fluid. If used at 30 weeks or later, it can cause the premature closure of a vital blood vessel in the baby's heart.

Toradol is specifically contraindicated for use during labor and delivery. It may interfere with uterine contractions and can negatively affect fetal blood circulation. Additionally, some evidence suggests that NSAIDs like ketorolac may temporarily affect a woman's ability to become pregnant.

Breastfeeding

Ketorolac is known to pass into breast milk in small amounts. While it may be used for short periods, it is important to discuss the potential risks and benefits with a doctor before breastfeeding while taking this medication.

Available Forms

Toradol is provided in formulations intended for short-term use. The available forms include:

• Oral Tablets: These are used only as a continuation of treatment that started with an injection.
• Intramuscular Injection: This form is administered by a healthcare professional into a muscle.
• Intravenous Injection: This form is administered by a healthcare professional directly into a vein.

The transition from injectable to oral therapy is common, but the medication is not intended for long-term use in any form.

FDA Approval and Indications

Toradol (ketorolac tromethamine) is approved by the U.S. Food and Drug Administration (FDA) for the short-term management of moderately severe acute pain that requires analgesia at the opioid level. It is indicated for use for a maximum of five days. Treatment usually begins with an injection (intravenous or intramuscular) and may be continued with oral tablets for the remainder of the five-day period.

Boxed Warnings

The FDA has issued several boxed warnings for Toradol, which is the most serious type of warning required for prescription drugs. These warnings highlight the following risks:

• Gastrointestinal Effects: Toradol can cause serious stomach and intestinal problems, including bleeding, ulcers, and holes (perforation). These conditions can occur at any time without warning and may be fatal.
• Cardiovascular Events: Like other non-aspirin NSAIDs, Toradol may increase the risk of serious heart attacks or strokes, which can be fatal. This risk may increase with longer use.
• Kidney Damage: The medication can cause serious kidney injury, particularly in patients with existing kidney disease or those who are dehydrated.
• Bleeding and Surgery: Toradol is contraindicated for use as a preventative medication before major surgery and is not recommended for use during labor and delivery due to the risk of excessive bleeding.

Regulatory Safety Updates

The FDA has strengthened existing warnings that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) increase the chance of a heart attack or stroke. Regulatory guidance emphasizes that Toradol should not be used for minor or chronic pain conditions and must not exceed the five-day treatment limit.

Gastrointestinal Risks

Toradol is a potent nonsteroidal anti-inflammatory drug (NSAID) that can cause irritation, ulcers, or holes in the stomach and intestines. Alcohol also irritates the digestive lining. When used together, the risk of developing severe gastrointestinal complications is much higher.

Individuals who regularly consume three or more alcoholic drinks per day are at a particularly high risk for stomach bleeding when taking NSAIDs like Toradol. Because Toradol is intended only for short-term use (up to 5 days) due to its high risk profile, it is generally recommended to avoid alcohol entirely during the course of treatment.

Signs of Complications

Seek immediate medical care if you experience any signs of stomach or intestinal bleeding while taking Toradol, such as:

• Black, bloody, or tarry stools
• Coughing up blood or vomit that looks like coffee grounds
• Severe or persistent stomach pain